Boston Scientific today announced FDA approval of its Agent drug-coated balloon (DCB), making it the first coronary DCB indicated for in-stent restenosis (ISR) in patients with coronary artery disease ...

A paclitaxel-coated device, Agent, has become the first coronary DCB in the United States to be approved for the treatment of in-stent restenosis (ISR), Boston Scientific announced today. The Food and ...

WASHINGTON, DC—-Results from the full cohort of patients treated with a newly approved DCB for in-stent restenosis confirm its superiority over an uncoated balloon, and investigators say it will ...

SAN FRANCISCO -- The Agent paclitaxel-coated balloon was better than conventional balloon angioplasty for in-stent restenosis (ISR), according to the AGENT IDE pivotal trial that will be used to ...

Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB While coronary stenting is commonly used to restore blood flow to the ...

The US Food and Drug Administration (FDA) has approved Boston Scientific's Agent Drug-Coated Balloon (DCB), the first coronary DCB for the treatment of coronary in-stent restenosis in patients with ...

First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence MARLBOROUGH, Mass., March 1, 2024 /PRNewswire/ -- ...

San Francisco — For the treatment of coronary artery in-stent restenosis, angioplasty with a drug-coated balloon (AGENT DCB; Boston Scientific) was superior to conventional balloon angioplasty in ...

Global medical device maker Boston Scientific recently reported that it had received CE (Conformité Européenne) approval for its Agent drug-coated balloon catheter for the coronary market. The Agent ...

Please provide your email address to receive an email when new articles are posted on . A novel coronary drug-coated balloon using a reduced dose of paclitaxel was noninferior at 1 year to a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...